UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 86-1832801 (State or other ju ...

LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this outpatient mental health services provider would post a loss of $0.09 per share when it actually produced a loss of $0.12, delivering a surprise of -33.33%. Over th ...

第一季度业绩 - 第一季度2024年收入为3.004亿美元，同比增长19%[2] - 临床医生基数增长15%，达到6,866名临床医生[2] - 第一季度就诊量增长15%，达到190万次[2] - 股权激励导致净亏损为2,110万美元，较去年同期净亏损3,420万美元有所减少[2] - 调整后的EBITDA为正2,770万美元，较去年同期的1,010万美元有较大增长[2] 2024年全年展望 - 全年2024年预期收入为11.9亿至12.4亿美元，中心利润预期为3.53亿至3.73亿美元，调整后的EBITDA预期为8.8亿至9.8亿美元[2] 第二季度业绩预期 - 第二季度2024年预计总收入为2.97亿至3.15亿美元，中心利润为8500万至9700万美元，调整后的EBITDA为2,000万至2,600万美元[5] 财务状况 - 2024年第一季度总收入为30.04亿美元，较2023年同期增长19.3%[15] - 2024年第一季度亏损为2.11亿美元，较2023年同期减少38.4%[15] - 经营活动现金流净额为-2.18亿美元，较2023年同期下降176.1%[16] - 调整后的中心利润为9.47亿美元，较2023年同期增长36.1%[17] - 调整后的息税折旧及摊销前利润为2.77亿美元，较2023年同期增长173.3%[17] 费用项目 - 战略举措费用为0.75亿美元，主要用于系统升级和扩张[18] - 房地产优化和重组费用为0.15亿美元，主要用于房地产优化计划[19] - 云软件实施成本摊销为0.01亿美元，包含在管理费用中[20] - 收购中心整合和其他费用为0.09亿美元，主要用于收购中心整合[21]

公司介绍 - LifeStance Health Group, Inc.将于2024年5月9日在市场开盘前发布2024年第一季度财报[1] - LifeStance成立于2017年，是全国最大的虚拟和面对面门诊心理健康护理提供商之一[5] - LifeStance及其支持的实践在33个州和550多个中心运营，雇佣约6600名精神科医生、高级护士、心理学家和治疗师[5] 财务信息 - LifeStance将于2024年5月9日上午8:30举行现场财报电话会议讨论第一季度业绩[1] - 可通过LifeStance投资者关系网站的活动和演示部分实时访问音频网络广播[3]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40478 LifeStance Health Group, Inc. (Exact name of Registrant as specified in its Charter) Delaware 86-1832801 (State or other jurisd ...

LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2023 Earnings Conference Call February 28, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President, Investor Relations Ken Burdick - Chief Executive Officer David Bourdon - Chief Financial Officer Danish Qureshi - President and Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JP Morgan Jack Senft - William Blair Dylan Finley - UBS Brian Tanquilut - Jefferies Stephanie Davis - Barclays Operator Good ...

Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Fourth Quarter and Full Year 2023 Results SCOTTSDALE, Ariz. – February 28, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2023. (All results compared to prior-year comparative period, unle ...

LifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Monica Prokocki - Vice President, Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Danish Qureshi - Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JP Morgan Jack Senft - William Blair Kevin Caliendo - UBS Jamie Perse - Goldman Sach Brian Tanquilut - Jefferies Gary Taylor - TD Cowen Oper ...

Reimagining Mental Health Q3 2023 Earnings Presentation • November 8, 2023 Forward-Looking Statements DISCLAIMERS Cautionary Note Regarding Forward-Looking Statements This presentation and related oral statements, including during any question and answer portion of the presentation, contain forward-looking statements about LifeStance Health Group, Inc. and its subsidiaries (“LifeStance”) and the industry in which LifeStance operates, including statements regarding: full-year and fourth-quarter guidance and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40478 LifeStance Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 86-1832801 (State or othe ...